ABSTRACT
In the United States, stimulants remain the approved pharmacotherapy of choice for adults with attention-deficit/hyperactivity disorder (ADHD). Many patients respond to these drugs, but stimulants also have a significant potential for misuse. This article suggests the “universal precautions” approach to reducing these risks while promoting appropriate medication use.
Footnotes
↵* Dr. Sinha has disclosed receiving funding through the Janssen Academic Research Mentorship Program and the American Society of Clinical Psychopharmacology Clinical Trial Fellowship award.
- Copyright © 2015 The Cleveland Clinic Foundation. All Rights Reserved.
